NCT01012271

Brief Summary

The purpose of our study is to evaluate the diagnostic accuracy of MR arthrography of the wrist at 1.5, 3.0, and 7.0T with wrist arthroscopy as reference standard.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2010

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 11, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 13, 2009

Completed
11 months until next milestone

Study Start

First participant enrolled

October 1, 2010

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2016

Completed
Last Updated

March 30, 2016

Status Verified

March 1, 2016

Enrollment Period

5.3 years

First QC Date

November 11, 2009

Last Update Submit

March 29, 2016

Conditions

Wrist Injuries

Keywords

Wrist abnormalities

Interventions

MRIOTHER

MR arthrography is used to evaluate wrist abnormalities

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

primary care clinic

You may qualify if:

  • age \>18;
  • clinical evidence for wrist joint abnormalities;
  • request for MR arthrography prior to wrist arthroscopy;
  • willingness to take part in our study with written informed consent;

You may not qualify if:

  • age\<18;
  • history of prior wrist surgery; systemic diseases e.g. rheumatoid arthritis;
  • infection; history of adverse contrast reactions;
  • contraindication for MR imaging (e.g. pacemaker, metallic implants, etc.);
  • history or possible signs of renal failure (see section "nephrogenic systemic fibrosis")

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Unknown Facility

Zurich, Switzerland

Location

MeSH Terms

Conditions

Wrist Injuries

Condition Hierarchy (Ancestors)

Arm InjuriesWounds and Injuries

Study Officials

  • 01 Studienregister MasterAdmins

    UniversitaetsSpital Zuerich

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
mg

Study Record Dates

First Submitted

November 11, 2009

First Posted

November 13, 2009

Study Start

October 1, 2010

Primary Completion

January 1, 2016

Study Completion

January 1, 2016

Last Updated

March 30, 2016

Record last verified: 2016-03

Locations

CH(1)